Home » ENCYSIVE SUBMITS THELIN RESPONSE TO FDA
ENCYSIVE SUBMITS THELIN RESPONSE TO FDA
Shares of Encysive Pharmaceuticals Inc. soared in early trading on Thursday as the pharmaceutical company said it submitted a complete response to the U.S. Food and Drug Administration regarding the company's new drug application for Thelin.
The
Houston Chronicle
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May